Blocklisting Interim Review Archives - Advanced Medical Solutions https://admedsol.com/message-type/blocklisting-interim-review/ Thu, 31 Aug 2023 13:49:46 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.4 https://admedsol.com/wp-content/uploads/2026/02/cropped-Web-Icon-32x32.png Blocklisting Interim Review Archives - Advanced Medical Solutions https://admedsol.com/message-type/blocklisting-interim-review/ 32 32 Block listing announcement https://admedsol.com/regulatory-news-announcements/block-listing-announcement-3/ Wed, 08 Mar 2023 14:56:25 +0000 https://admedsol1stg.wpenginepowered.com/investor-relations/regulatory-news-announcements/no-rid-4886/ RNS Number : 3374S Advanced Medical Solutions Grp PLC 08 March 2023     8 March 2023             Advanced Medical Solutions Group plc (“AMS”, the “Company” or the “Group”)   Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, makes the following notification pursuant to Schedule Six of the AIM […]

The post Block listing announcement appeared first on Advanced Medical Solutions.

]]>

RNS Number : 3374S
Advanced Medical Solutions Grp PLC
08 March 2023
 

 

8 March 2023

            Advanced Medical Solutions Group plc

(“AMS”, the “Company” or the “Group”)

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block admission arrangements:

 

Name of applicant:

Advanced Medical Solutions Group plc

Name of scheme:

Block Scheme for:

1.   Deferred Share Bonus Scheme

2.   Enterprise Management Incentive Scheme

3.   Company Share Option Plan

4.   Unapproved Executive Share Option Scheme

5.   Long Term Incentive Plan

6.   Deferred Annual Bonus Scheme

Period of return:

From:

6 September 2022

To:

5 March 2023

Balance of unallotted securities under scheme(s) from previous return:

1. 186,786

2. Nil

3. 214,337

4. 671,754

5. 278,220

6. 248,616

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

1. Nil

2. Nil

3. Nil

4. Nil

5. Nil

6. Nil

Less:  Number of securities issued/allotted under scheme(s) during period:

1. 34,107

2. Nil

3. 32,084

4. 84,802

5. 4,113

6. 2,275

 

 

 

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

1. 152,679

2. Nil

3. 182,253

4. 586,952

5. 274,107

6. 246,341

Number and class of securities originally listed and the date of admission:

4,476,264 ordinary shares of 5p each on 6 September 2018

 

 

Name of contact:

Eddie Johnson

Telephone number of contact:

01606 545506

 

 

For further information, please visit www.admedsol.com or contact:

 

 

Advanced Medical Solutions Group plc

Tel: 44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Eddie Johnson, Chief Financial Officer

Michael King, Investor Relations



 

Consilium Strategic Communications

Tel: 44 (0) 20 3709 5700

Matthew Neal / Lucy Featherstone

 



Investec Bank PLC (NOMAD & Broker)

Tel: 44 (0) 20 7597 5970

Gary Clarence / David Anderson




HSBC Bank plc (Broker)

Tel: 44 (0) 20 7991 8888

Sam McLennan / Joe Weaving / Stephanie Cornish


 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 
 

BLRUPUCAWUPWGCR

The post Block listing announcement appeared first on Advanced Medical Solutions.

]]> Block listing announcement https://admedsol.com/regulatory-news-announcements/block-listing-announcement-2/ Thu, 08 Sep 2022 16:53:02 +0000 https://admedsol1stg.wpenginepowered.com/investor-relations/regulatory-news-announcements/no-rid-4833/ RNS Number : 8361Y Advanced Medical Solutions Grp PLC 08 September 2022     8 September 2022             Advanced Medical Solutions Group plc (“AMS”, the “Company” or the “Group”)   Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, makes the following notification pursuant to Schedule Six of the AIM […]

The post Block listing announcement appeared first on Advanced Medical Solutions.

]]>

RNS Number : 8361Y
Advanced Medical Solutions Grp PLC
08 September 2022
 

 

8 September 2022

            Advanced Medical Solutions Group plc

(“AMS”, the “Company” or the “Group”)

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block admission arrangements:

 

Name of applicant:

Advanced Medical Solutions Group plc

Name of scheme:

Block Scheme for:

1.   Deferred Share Bonus Scheme

2.   Enterprise Management Incentive Scheme

3.   Company Share Option Plan

4.   Unapproved Executive Share Option Scheme

5.   Long Term Incentive Plan

6.   Deferred Annual Bonus Scheme

Period of return:

From:

6 March 2022

To:

5 September 2022

Balance of unallotted securities under scheme(s) from previous return:

1. 268,039

2. Nil

3. 215,337

4. 719,560

5. 695,899

6. 294,096

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

1. Nil

2. Nil

3. Nil

4. Nil

5. Nil

6. Nil

Less:  Number of securities issued/allotted under scheme(s) during period:

1. 81,253

2. Nil

3. 1,000

4. 47,806

5. 417,679

6. 45,480

 

 

 

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

1. 186,786

2. Nil

3. 214,337

4. 671,754

5. 278,220

6. 248,616

Number and class of securities originally listed and the date of admission:

4,476,264 ordinary shares of 5p each on 6 September 2018

 

 

Name of contact:

Eddie Johnson

Telephone number of contact:

01606 545506

 

 

For further information, please visit www.admedsol.com or contact:

 

 

Advanced Medical Solutions Group plc

Tel: 44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Eddie Johnson, Chief Financial Officer

Michael King, Investor Relations



 

Consilium Strategic Communications

Tel: 44 (0) 20 3709 5700

Mary-Jane Elliott / Matthew Neal / Matthew Cole

 



Investec Bank PLC (NOMAD & Broker)

Tel: 44 (0) 20 7597 5970

Daniel Adams / Gary Clarence




HSBC Bank plc (Broker)

Tel: 44 (0) 20 7991 8888

Sam McLennan / Joe Weaving / Stephanie Cornish


 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 
 

BLRDZGGLKRRGZZM

The post Block listing announcement appeared first on Advanced Medical Solutions.

]]> Block listing Interim Review https://admedsol.com/regulatory-news-announcements/block-listing-interim-review-6/ Wed, 09 Mar 2022 13:17:56 +0000 https://admedsol1stg.wpenginepowered.com/investor-relations/regulatory-news-announcements/no-rid-4717/ RNS Number : 2195E Advanced Medical Solutions Grp PLC 09 March 2022   9 March 2022             Advanced Medical Solutions Group plc (“AMS”, the “Company” or the “Group”)   Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, makes the following notification pursuant to Schedule Six of the AIM Rules for […]

The post Block listing Interim Review appeared first on Advanced Medical Solutions.

]]>

RNS Number : 2195E
Advanced Medical Solutions Grp PLC
09 March 2022
 

9 March 2022

            Advanced Medical Solutions Group plc

(“AMS”, the “Company” or the “Group”)

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block admission arrangements:

 

Name of applicant:

Advanced Medical Solutions Group plc

Name of scheme:

Block Scheme for:

1.   Deferred Share Bonus Scheme

2.   Enterprise Management Incentive Scheme

3.   Company Share Option Plan

4.   Unapproved Executive Share Option Scheme

5.   Long Term Incentive Plan

6.   Deferred Annual Bonus Scheme

Period of return:

From:

6 September 2021

To:

5 March 2022

Balance of unallotted securities under scheme(s) from previous return:

1. 311,937

2. Nil

3. 291,561

4. 881,974

5. 696,634

6. 296,669

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

1. Nil

2. Nil

3. Nil

4. Nil

5. Nil

6. Nil

Less:  Number of securities issued/allotted under scheme(s) during period:

1. 43,898

2. Nil

3. 76,224

4. 162,414

5. 735

6. 2,573

 

 

 

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

1. 268,039

2. Nil

3. 215,337

4. 719,560

5. 695,899

6. 294,096

Number and class of securities originally listed and the date of admission:

4,476,264 ordinary shares of 5p each on 6 September 2018

 

 

Name of contact:

Eddie Johnson

Telephone number of contact:

01606 545506

 

 

For further information, please visit www.admedsol.com or contact:

 

 

Advanced Medical Solutions Group plc

Tel: 44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Eddie Johnson, Chief Financial Officer

Michael King, Investor Relations




Consilium Strategic Communications

Tel: 44 (0) 20 3709 5700

Mary-Jane Elliott / Matthew Neal / Matthew Cole




Investec Bank PLC – Nominated Adviser & Broker

Tel: 44 (0) 20 7597 5970

Daniel Adams / Gary Clarence




HSBC Bank plc – Broker

Tel: 44 (0) 20 7991 8888

Sam McLennan / Joe Weaving / Stephanie Cornish


 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 
 

BLRUPUMGWUPPGWB

The post Block listing Interim Review appeared first on Advanced Medical Solutions.

]]> Block listing announcement https://admedsol.com/regulatory-news-announcements/block-listing-announcement/ Fri, 17 Sep 2021 13:13:17 +0000 https://admedsol.wpengine.com/investor-relations/regulatory-news-announcements/no-rid-4635/ RNS Number : 1875M Advanced Medical Solutions Grp PLC 17 September 2021   17 September 2021             Advanced Medical Solutions Group plc (“AMS”, the “Company” or the “Group”)   Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, makes the following notification pursuant to Schedule Six of the AIM […]

The post Block listing announcement appeared first on Advanced Medical Solutions.

]]>

RNS Number : 1875M
Advanced Medical Solutions Grp PLC
17 September 2021
 

17 September 2021

            Advanced Medical Solutions Group plc

(“AMS”, the “Company” or the “Group”)

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block admission arrangements:

 

Name of applicant:

Advanced Medical Solutions Group plc

Name of scheme:

Block Scheme for:

1.   Deferred Share Bonus Scheme

2.   Enterprise Management Incentive Scheme

3.   Company Share Option Plan

4.   Unapproved Executive Share Option Scheme

5.   Long Term Incentive Plan

6.   Deferred Annual Bonus Scheme

Period of return:

From:

6 March 2021

To:

5 September 2021

Balance of unallotted securities under scheme(s) from previous return:

1. 452,678

2. Nil

3. 317,513

4. 928,904

5. 696,634

6. 344,642

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

1. Nil

2. Nil

3. Nil

4. Nil

5. Nil

6. Nil

Less:  Number of securities issued/allotted under scheme(s) during period:

1. 140,741

2. Nil

3. 25,952

4. 46,930

5. Nil

6. 47,973

 

 

 

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

1. 311,937

2. Nil

3. 291,561

4. 881,974

5. 696,634

6. 296,669

Number and class of securities originally listed and the date of admission:

4,476,264 ordinary shares of 5p each on 6 September 2018

 

 

Name of contact:

Eddie Johnson

Telephone number of contact:

01606 545506

 

 

For further information, please visit www.admedsol.com or contact:

 

 

Advanced Medical Solutions Group plc

Tel: 44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Eddie Johnson, Chief Financial Officer

Michael King, Investor Relations Manager




Consilium Strategic Communications

Tel: 44 (0) 20 3709 5700

Mary-Jane Elliott / Matthew Neal / Matthew Cole




Investec Bank PLC – Nominated Adviser & Broker

Tel: 44 (0) 20 7597 5970

Daniel Adams / Gary Clarence


 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 
 

BLRMZGMLZNGGMZM

The post Block listing announcement appeared first on Advanced Medical Solutions.

]]> Block listing Interim Review https://admedsol.com/regulatory-news-announcements/block-listing-interim-review-5/ Mon, 08 Mar 2021 12:24:33 +0000 https://admedsol.wpengine.com/investor-relations/regulatory-news-announcements/no-rid-4410/ RNS Number : 5110R Advanced Medical Solutions Grp PLC 08 March 2021   8 March 2021             Advanced Medical Solutions Group plc (“AMS”, the “Company” or the “Group”)   Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, makes the following notification pursuant to Schedule Six of the AIM […]

The post Block listing Interim Review appeared first on Advanced Medical Solutions.

]]>

RNS Number : 5110R
Advanced Medical Solutions Grp PLC
08 March 2021
 

8 March 2021

            Advanced Medical Solutions Group plc

(“AMS”, the “Company” or the “Group”)

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block admission arrangements:

 

Name of applicant:

Advanced Medical Solutions Group plc

Name of scheme:

Block Scheme for:

1.   Deferred Share Bonus Scheme

2.   Enterprise Management Incentive Scheme

3.   Company Share Option Plan

4.   Unapproved Executive Share Option Scheme

5.   Long Term Incentive Plan

6.   Deferred Annual Bonus Scheme

Period of return:

From:

6 September 2020

To:

5 March 2021

Balance of unallotted securities under scheme(s) from previous return:

1. 524,148

2. Nil

3. 317,513

4. 928,904

5. 770,418

6. 367,493

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

1. Nil

2. Nil

3. Nil

4. Nil

5. Nil

6. Nil

Less:  Number of securities issued/allotted under scheme(s) during period:

1. 71,470

2. Nil

3. Nil

4. Nil

5. 73,784

6. 22,851

 

 

 

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

1. 452,678

2. Nil

3. 317,513

4. 928,904

5. 696,634

6. 344,642

Number and class of securities originally listed and the date of admission:

4,476,264 ordinary shares of 5p each on 6 September 2018

 

 

Name of contact:

Eddie Johnson

Telephone number of contact:

01606 545506

 

 

For further information, please visit www.admedsol.com or contact:

 

 

Advanced Medical Solutions Group plc

Tel: 44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Eddie Johnson, Chief Financial Officer




Consilium Strategic Communications

Tel: 44 (0) 20 3709 5700

Mary-Jane Elliott / Matthew Neal / Olivia Manser




Investec Bank PLC – Nominated Adviser & Broker

Tel: 44 (0) 20 7597 5970

Daniel Adams / Patrick Robb / Gary Clarence


 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 
 

BLRUPUCUWUPGGPR

The post Block listing Interim Review appeared first on Advanced Medical Solutions.

]]> Block listing Interim Review https://admedsol.com/regulatory-news-announcements/block-listing-interim-review-4/ Tue, 15 Sep 2020 14:48:46 +0000 https://admedsol.wpengine.com/investor-relations/regulatory-news-announcements/no-rid-4275/ RNS Number : 0764Z Advanced Medical Solutions Grp PLC 15 September 2020   15 September 2020             Advanced Medical Solutions Group plc (“AMS”, the “Company” or the “Group”)   Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, makes the following notification pursuant to Schedule Six of the AIM […]

The post Block listing Interim Review appeared first on Advanced Medical Solutions.

]]>

RNS Number : 0764Z
Advanced Medical Solutions Grp PLC
15 September 2020
 

15 September 2020

            Advanced Medical Solutions Group plc

(“AMS”, the “Company” or the “Group”)

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block admission arrangements:

 

Name of applicant:

Advanced Medical Solutions Group plc

Name of scheme:

Block Scheme for:

1.   Deferred Share Bonus Scheme

2.   Enterprise Management Incentive Scheme

3.   Company Share Option Plan

4.   Unapproved Executive Share Option Scheme

5.   Long Term Incentive Plan

6.   Deferred Annual Bonus Scheme

Period of return:

From:

6 March 2020

To:

5 September 2020

Balance of unallotted securities under scheme(s) from previous return:

1. 627,091

2. 15,000

3. 323,733

4. 954,197

5. 776,034

6. 407,111

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

1. Nil

2. Nil

3. Nil

4. Nil

5. Nil

6. Nil

Less:  Number of securities issued/allotted under scheme(s) during period:

1. 102,943

2. 15,000

3. 6,220

4. 25,293

5. 5,616

6. 39,618

 

 

 

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

1. 524,148

2. Nil

3. 317,513

4. 928,904

5. 770,418

6. 367,493

Number and class of securities originally listed and the date of admission:

4,476,264 ordinary shares of 5p each on 6 September 2018

 

 

Name of contact:

Eddie Johnson

Telephone number of contact:

01606 545506

 

 

For further information, please visit www.admedsol.com or contact:

 

 

Advanced Medical Solutions Group plc

Tel: 44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Eddie Johnson, Chief Financial Officer




Consilium Strategic Communications

Tel: 44 (0) 20 3709 5700

Mary-Jane Elliott / Matthew Neal / Olivia Manser




Investec Bank PLC – Nominated Adviser & Broker

Tel: 44 (0) 20 7597 5970

Daniel Adams / Patrick Robb / Gary Clarence


 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 
 

BLRGPUQCBUPUGWA

The post Block listing Interim Review appeared first on Advanced Medical Solutions.

]]> Block listing Interim Review https://admedsol.com/regulatory-news-announcements/block-listing-interim-review-3/ Tue, 10 Mar 2020 07:00:07 +0000 https://admedsol.wpengine.com/investor-relations/regulatory-news-announcements/no-rid-4018/ RNS Number : 5156F Advanced Medical Solutions Grp PLC 10 March 2020     10 March 2020 Advanced Medical Solutions Group plc (“AMS”, the “Company” or the “Group”)   Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, makes the following notification pursuant to Schedule Six of the AIM […]

The post Block listing Interim Review appeared first on Advanced Medical Solutions.

]]>
RNS Number : 5156F
Advanced Medical Solutions Grp PLC
10 March 2020
 

 

10 March 2020

Advanced Medical Solutions Group plc

(“AMS”, the “Company” or the “Group”)

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block admission arrangements:

 

Name of applicant:

Advanced Medical Solutions Group plc

Name of scheme:

Block Scheme for:

1.   Deferred Share Bonus Scheme

2.   Enterprise Management Incentive Scheme

3.   Company Share Option Plan

4.   Unapproved Executive Share Option Scheme

5.   Long Term Incentive Plan

6.   Deferred Annual Bonus Scheme

Period of return:

From:

6 September 2019

To:

6 March 2020

Balance of unallotted securities under scheme(s) from previous return:

1. 661,554

2. 38,000

3. 323,733

4. 1,037,228

5. 776,034

6. 407,111

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

1. Nil

2. Nil

3. Nil

4. Nil

5. Nil

6. Nil

Less:  Number of securities issued/allotted under scheme(s) during period:

1. 34,463

2. 23,000

3. Nil

4. 83,031

5. Nil

6. Nil

 

 

 

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

1. 627,091

2. 15,000

3. 323,733

4. 954,197

5. 776,034

6. 407,111

Number and class of securities originally listed and the date of admission:

4,476,264 ordinary shares of 5p each on 6 September 2018

 
         

 

Name of contact:

Eddie Johnson

Telephone number of contact:

01606 545506

 

 

For further information, please visit www.admedsol.com or contact:

 

Advanced Medical Solutions Group plc

Tel: 44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Eddie Johnson, Chief Financial Officer

 

 

 

Consilium Strategic Communications

Tel: 44 (0) 20 3709 5700

Mary-Jane Elliott / Matthew Neal / Nicholas Brown / Olivia Manser

 

 

 

Investec Bank PLC – Nominated Adviser & Broker

Tel: 44 (0) 20 7597 5970

Daniel Adams / Patrick Robb / Gary Clarence

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 

END

 
 

BLRUPUBPWUPUGBB

The post Block listing Interim Review appeared first on Advanced Medical Solutions.

]]> Block listing Interim Review https://admedsol.com/regulatory-news-announcements/block-listing-interim-review-2/ Fri, 06 Sep 2019 07:00:06 +0000 https://admedsol.wpengine.com/investor-relations/regulatory-news-announcements/no-rid-3811/ RNS Number : 4049L Advanced Medical Solutions Grp PLC 06 September 2019   6 September 2019             Advanced Medical Solutions Group plc (“AMS”, the “Company” or the “Group”)   Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, makes the following notification pursuant to Schedule Six of the AIM […]

The post Block listing Interim Review appeared first on Advanced Medical Solutions.

]]>
RNS Number : 4049L
Advanced Medical Solutions Grp PLC
06 September 2019
 

6 September 2019

            Advanced Medical Solutions Group plc

(“AMS”, the “Company” or the “Group”)

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block admission arrangements:

 

Name of applicant:

Advanced Medical Solutions Group plc

Name of scheme:

Block Scheme for:

1.   Deferred Share Bonus Scheme

2.   Enterprise Management Incentive Scheme

3.   Company Share Option Plan

4.   Unapproved Executive Share Option Scheme

5.   Long Term Incentive Plan

6.   Deferred Annual Bonus Scheme

Period of return:

From:

6 March 2019

To:

5 September 2019

Balance of unallotted securities under scheme(s) from previous return:

1. 795,647

2. 38,000

3. 439,808

4. 1,454,703

5. 1,224,399

6. 486,987

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

1. Nil

2. Nil

3. Nil

4. Nil

5. Nil

6. Nil

Less:  Number of securities issued/allotted under scheme(s) during period:

1. 134,093

2. Nil

3. 116,075

4. 417,475

5. 448,365

6. 79,876

 

 

 

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

1. 661,554

2. 38,000

3. 323,733

4. 1,037,228

5. 776,034

6. 407,111

Number and class of securities originally listed and the date of admission:

4,476,264 ordinary shares of 5p each on 6 September 2018

 

 

Name of contact:

Eddie Johnson

Telephone number of contact:

01606 545506

 

 

For further information, please visit www.admedsol.com or contact:

 

Advanced Medical Solutions Group plc

Tel: 44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Eddie Johnson, Chief Financial Officer




Consilium Strategic Communications

Tel: 44 (0) 20 3709 5700

Mary-Jane Elliott / Matthew Neal / Nicholas Brown / Olivia Manser




Investec Bank PLC – Nominated Adviser & Broker

Tel: 44 (0) 20 7597 5970

Daniel Adams / Patrick Robb / Gary Clarence


 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 

END

 
 

BLRUGUCABUPBGWA

The post Block listing Interim Review appeared first on Advanced Medical Solutions.

]]> Block listing Interim Review https://admedsol.com/regulatory-news-announcements/block-listing-interim-review/ Wed, 06 Mar 2019 09:13:16 +0000 https://admedsol.wpengine.com/investor-relations/regulatory-news-announcements/no-rid-3724/ RNS Number : 0149S Advanced Medical Solutions Grp PLC 06 March 2019   6 March 2019             Advanced Medical Solutions Group plc (“AMS”, the “Company” or the “Group”)   Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, makes the following notification pursuant to Schedule Six of the AIM […]

The post Block listing Interim Review appeared first on Advanced Medical Solutions.

]]>
RNS Number : 0149S
Advanced Medical Solutions Grp PLC
06 March 2019
 

6 March 2019

            Advanced Medical Solutions Group plc

(“AMS”, the “Company” or the “Group”)

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block admission arrangements:

 

Name of applicant:

Advanced Medical Solutions Group plc

Name of scheme:

Block Scheme for:

1.   Deferred Share Bonus Scheme

2.   Enterprise Management Incentive Scheme

3.   Company Share Option Plan

4.   Unapproved Executive Share Option Scheme

5.   Long Term Incentive Plan

6.   Deferred Annual Bonus Scheme

Period of return:

From:

6 September 2018

To:

5 March 2019

Balance of unallotted securities under scheme(s) from previous return:

1. 804,569

2. 43,172

3. 439,808

4. 1,477,329

5. 1,224,399

6. 486,987

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

1. Nil

2. Nil

3. Nil

4. Nil

5. Nil

6. Nil

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

1. 8,922

2. 5,172

3. Nil

4. 22,626

5. Nil

6. Nil

 

 

 

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

1. 795,647

2. 38,000

3. 439,808

4. 1,454,703

5. 1,224,399

6. 486,987

 

Name of contact:

Eddie Johnson

Telephone number of contact:

01606 545506

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 

END

 
 

BLRUGUUGWUPBUBQ

The post Block listing Interim Review appeared first on Advanced Medical Solutions.

]]> Blocklisting Six Monthly Return https://admedsol.com/regulatory-news-announcements/blocklisting-six-monthly-return-2/ Thu, 30 Apr 2009 15:09:00 +0000 https://admedsol.wpengine.com/investor-relations/shareholder/regulatory-news-announcements/843/ RNS Number : 5133R Advanced Medical Solutions Grp PLC 30 April 2009    BLOCKLISTING SIX MONTHLY RETURN Information provided on this form must be typed or printed electronically. To:  The FSA Date: 30 April 2009 1. Name of applicant: Advanced Medical Solutions Group plc 2. Name of scheme Unapproved Executive EMI Share Option Scheme 3. Period of return: […]

The post Blocklisting Six Monthly Return appeared first on Advanced Medical Solutions.

]]> RNS Number : 5133R
Advanced Medical Solutions Grp PLC
30 April 2009
 



BLOCKLISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically.

To:  The FSA

Date: 30 April 2009

1. Name of applicant:

Advanced Medical Solutions Group plc

2. Name of scheme

Unapproved Executive EMI Share Option Scheme

3. Period of return:

From

30 April 2008

To

30 April 2009

4. Balance under scheme from previous return:

1,625,337

5. The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return

Nil

6. Number of securities issued/allotted under scheme during period:

878,905

7 Balance under scheme not yet issued/allotted at end of period

746,432

8. Number and class of securities originally listed and the date of admission

2,000,000 Ordinary Shares at 5p on 25 April 2007

9. Total number of securities in issue at the end of the period

144,294,916 shares of 5p each

Name of contact

Mary Tavener

Address of contact

Advanced Medical Solutions Group plc, Road Three, Winsford Industrial Estate, Winsford, Cheshire, CW7 3PD

Telephone number of  contact 

    01606 545502

Signed by …………………………………..

   Director.


This information is provided by RNS
The company news service from the London Stock Exchange
 

END

 
 

BLRURRSRKWRSOAR

The post Blocklisting Six Monthly Return appeared first on Advanced Medical Solutions.

]]>